A guide to <scp>COVID</scp> ‐19 antiviral therapeutics: a summary and perspective of the antiviral weapons against <scp>SARS‐CoV</scp> ‐2 infection-Reference-Cited by-同舟云学术

A guide to COVID ‐19 antiviral therapeutics: a summary and perspective of the antiviral weapons against SARS‐CoV ‐2 infection

Published:2022-11-05 Issue: Volume: Page:
ISSN:1742-464X
Container-title:The FEBS Journal
language:en
Short-container-title:The FEBS Journal

Author:

Brady Drugan K.¹,Gurijala Aashi R.¹,Huang Liyu¹,Hussain Ali A.¹,Lingan Audrey L.¹,Pembridge Olivia G.¹,Ratangee Brina A.¹,Sealy Tristan T.¹,Vallone Kyle T.¹^ORCID,Clements Thomas P.¹^ORCID

Affiliation:

1. Department of Biological Sciences Vanderbilt University Nashville TN USA

Publisher

Wiley

Subject

Cell Biology,Molecular Biology,Biochemistry

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/febs.16662

Reference208 articles.

1. A Guide to COVID‐19: a global pandemic caused by the novel coronavirus SARS‐CoV‐2

2. Efficacy of covid‐19 vaccines in immunocompromised patients: systematic review and meta‐analysis;Lee ARYB;BMJ,2022

3. Revisiting COVID-19 vaccine hesitancy around the world using data from 23 countries in 2021

4. The Human Coronavirus Disease COVID-19: Its Origin, Characteristics, and Insights into Potential Drugs and Its Mechanisms

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bebtelovimab‐bound SARS‐CoV‐2 RBD mutants: resistance profiling and validation with escape mutations, clinical results, and viral genome sequences;FEBS Letters;2024-08-06

2. Recomendaciones para el diagnóstico y tratamiento de las vasculitis asociadas a anticuerpos anticitoplasma de neutrófilo;Nefrología;2024-08

3. Inhibition of SARS-CoV-2 Replication by Self-Assembled siRNA Nanoparticles Targeting Multiple Highly Conserved Viral Sequences;Viruses;2024-07-03

4. Anti-SARS-CoV-2 glyco-humanized polyclonal antibody XAV-19: phase II/III randomized placebo-controlled trial shows acceleration to recovery for mild to moderate patients with COVID-19;Frontiers in Immunology;2024-04-17

5. Synergism between remdesivir and ribavirin leads to SARS‐CoV‐2 extinction in cell culture;British Journal of Pharmacology;2024-04-14